Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00221455 · ClinicalTrials.gov registry record · Phase 1
The Potential of Technology to Improve Chronic Disease Management and Quality of Care
A Phase 1 study, sponsored by Robert Wood Johnson Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 1,000
- Enrollment target
NCT00221455: Completed Phase 1 study, sponsored by Robert Wood Johnson Foundation.
NCT00221455 is a Phase 1 study that has completed, run by Robert Wood Johnson Foundation. The registered enrollment target is 1,000 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1567% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00221455, a Phase 1 study, has completed, sponsored by Robert Wood Johnson Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
We seek to determine if patient data entry, data entered based alerts, and data review in a secure patient portal may provide a sustainable approach to improve diabetic outcomes in a cost effective manner. We plan to study the extent to which the portal can improve diabetic outcomes and quality of care. We recognize, however, that some patients will be more predisposed to adopting technology and some will be more predisposed to improving their compliance than others. Hence, we will also develop and test interventions that may improve adoption and compliance. The goals of the proposed study are: 1) to assess whether a web portal will improve care outcomes in diabetic patients; 2a) to describe the characteristics of patients whose health behavior improves over the study period; 2b) to describe the characteristics of patients who adopt the web portal-based disease management technology; 3) to develop and test targeted interventions to increase the adoption of the web portal and improve patient health behavior; and 4) to monitor the ongoing costs associated with the web portal and patient healthcare resource utilization, and to monitor the incremental costs of the interventions designed to improve utilization of the technology and patient compliance with their diabetic regimens.
Interventions
- BEHAVIORAL Patient diabetic self-management using the diabetic patient portal tools
- BEHAVIORAL A variety of educational interventions for non-adopters of the technology, and for non-compliant patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2004-09 |
| Est. Completion | 2007-09 |
| Phase | Phase 1 |
What the finished NCT00221455 record still lists
NCT00221455 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1567% higher).
The record links to 0 conditions, and to 2 interventions - of which Patient diabetic self-management using the diabetic patient portal tools is the first listed.
NCT00221455 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00221455 about?
NCT00221455 is a clinical study titled "The Potential of Technology to Improve Chronic Disease Management and Quality of Care". We seek to determine if patient data entry, data entered based alerts, and data review in a secure patient portal may provide a sustainable approach to improve diabetic outcomes in a cost effective manner. We plan to study the extent to which the portal can improve diabetic outcomes and quality of c...
What is the current status of trial NCT00221455?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1,000 participants. The study started on 2004-09. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00221455?
The interventions under investigation include: Patient diabetic self-management using the diabetic patient portal tools (BEHAVIORAL), A variety of educational interventions for non-adopters of the technology, and for non-compliant patients. (BEHAVIORAL).
Who is sponsoring clinical trial NCT00221455?
This trial is sponsored by Robert Wood Johnson Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00221455's enrollment target sits among peer trials
1,000 7th of 2000 higher than 1,994 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia